Melanie Sena

NIH, 10 biopharmaceutical companies, and several nonprofit organizations form a partnership to develop new treatments earlier for Alzheimer's, type 2 diabetes, and autoimmune disorders.

EMD Millipore's new Drypour packaging system helps minimize caking of pharmaceutical raw materials.

Neolpharma opens its new Development and Innovation Center (CEDIPROF) for pharmaceutical products in Puerto Rico.

Content Packages Accelerate MBR Creation

FactoryTalk Software Increases Flexibility

Work-in-Process Tracking Software

Software Expands Plant-Specific Analysis

PharmaCell enters an agreement purchase TiGenix therapy production facility.

Mayne Pharma appoints Stefan Cross as president of its US division.

Solvias appoints Karen Huebscher as its new CEO.

Jeff Yuen had been appointed executive vice-president, global quality for combined companies.

Optima pharma GmbH appoints Stephan Reuter as its new CEO.

Eurofins MWG Operon expands its exome sequencing services with the Ion Proton Next Generation Sequencer.

AstraZeneca and Bristol-Myers Squibb Diabetes Alliance provides a $5 million grant to the American Diabetes Association.

Teva reports FDA approval for three-times-a-week Copaxone 40 mg/mL.

Covance appoints Barry J. Goldstein as its new vice-president of Clinical Development Services and Global Therapeutic Area Head.

Caron's New Environmental Test Chambers and Refrigerated Incubators

Shire appoints Susan Kilsby as its New Chairman.

CS Inspection Machine Improves Efficiency

Janssen's donation program will improve access to the company's approved HIV medicines for children and adolescents in sub-Saharan Africa.

Ribbon Blender Model 42N-270 Increases Performance

Former US President Jimmy Carter and Pfizer commemorate the 15th anniversary of the International Trachoma Initiative to end blinding trachoma by the year 2020.

ALpHA G Capsule Filter for Single-Use Systems

Gericke N200 Nibbler Provides Size Reduction

The Bristol-Myers Squibb Foundation is awarding 10 grants to fund programs for veterans and their families.

Supernus Pharmaceuticals receives FDA approval of Orenitram for the treatment of pulmonary arterial hypertension.

Encap will collaborate with Lipocine to manufacture Lipcine's oral testosterone product, LPCN 1021, for Phase III clinical trials.

Bind Therapeutics amends its development and commercialization collaboration agreement with Amgen.

Everett Laboratories acquires Quinnova Pharmaceuticals, a specialty pharmaceutical company.

Merck and GlaxoSmithKline begin clinical trial of pazopanib for the treatment of advanced renal-cell carcinoma.